nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—SLC22A6—Captopril—systemic scleroderma	0.26	0.76	CbGbCtD
Cidofovir—SLC22A6—Methotrexate—systemic scleroderma	0.0822	0.24	CbGbCtD
Cidofovir—TYMP—endothelium—systemic scleroderma	0.0116	0.265	CbGeAlD
Cidofovir—TYMP—blood vessel—systemic scleroderma	0.0107	0.244	CbGeAlD
Cidofovir—TYMP—connective tissue—systemic scleroderma	0.00547	0.125	CbGeAlD
Cidofovir—TYMP—smooth muscle tissue—systemic scleroderma	0.005	0.114	CbGeAlD
Cidofovir—TYMP—digestive system—systemic scleroderma	0.00395	0.0904	CbGeAlD
Cidofovir—TYMP—tendon—systemic scleroderma	0.00376	0.086	CbGeAlD
Cidofovir—TYMP—lung—systemic scleroderma	0.0033	0.0755	CbGeAlD
Cidofovir—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000432	CcSEcCtD
Cidofovir—Feeling abnormal—Leflunomide—systemic scleroderma	0.000265	0.000431	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000265	0.000431	CcSEcCtD
Cidofovir—Nausea—Mometasone—systemic scleroderma	0.000264	0.00043	CcSEcCtD
Cidofovir—Anorexia—Lisinopril—systemic scleroderma	0.000263	0.000429	CcSEcCtD
Cidofovir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000263	0.000428	CcSEcCtD
Cidofovir—Weight increased—Prednisone—systemic scleroderma	0.000262	0.000428	CcSEcCtD
Cidofovir—Ataxia—Methotrexate—systemic scleroderma	0.000262	0.000427	CcSEcCtD
Cidofovir—Pain—Mycophenolic acid—systemic scleroderma	0.000262	0.000427	CcSEcCtD
Cidofovir—Constipation—Mycophenolic acid—systemic scleroderma	0.000262	0.000427	CcSEcCtD
Cidofovir—Weight decreased—Prednisone—systemic scleroderma	0.000261	0.000425	CcSEcCtD
Cidofovir—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000424	CcSEcCtD
Cidofovir—Hyperglycaemia—Prednisone—systemic scleroderma	0.00026	0.000424	CcSEcCtD
Cidofovir—Cough—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000421	CcSEcCtD
Cidofovir—Hypotension—Lisinopril—systemic scleroderma	0.000258	0.00042	CcSEcCtD
Cidofovir—Dizziness—Captopril—systemic scleroderma	0.000258	0.00042	CcSEcCtD
Cidofovir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000418	CcSEcCtD
Cidofovir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000417	CcSEcCtD
Cidofovir—Urticaria—Leflunomide—systemic scleroderma	0.000255	0.000416	CcSEcCtD
Cidofovir—Body temperature increased—Leflunomide—systemic scleroderma	0.000254	0.000414	CcSEcCtD
Cidofovir—Abdominal pain—Leflunomide—systemic scleroderma	0.000254	0.000414	CcSEcCtD
Cidofovir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000253	0.000412	CcSEcCtD
Cidofovir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000411	CcSEcCtD
Cidofovir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000411	CcSEcCtD
Cidofovir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000411	CcSEcCtD
Cidofovir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000252	0.000411	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000252	0.00041	CcSEcCtD
Cidofovir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000251	0.00041	CcSEcCtD
Cidofovir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000251	0.000408	CcSEcCtD
Cidofovir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000251	0.000408	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000408	CcSEcCtD
Cidofovir—Insomnia—Lisinopril—systemic scleroderma	0.00025	0.000407	CcSEcCtD
Cidofovir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000406	CcSEcCtD
Cidofovir—Paraesthesia—Lisinopril—systemic scleroderma	0.000248	0.000404	CcSEcCtD
Cidofovir—Vomiting—Captopril—systemic scleroderma	0.000248	0.000404	CcSEcCtD
Cidofovir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000402	CcSEcCtD
Cidofovir—Dyspnoea—Lisinopril—systemic scleroderma	0.000246	0.000401	CcSEcCtD
Cidofovir—Rash—Captopril—systemic scleroderma	0.000246	0.000401	CcSEcCtD
Cidofovir—Dermatitis—Captopril—systemic scleroderma	0.000246	0.0004	CcSEcCtD
Cidofovir—Somnolence—Lisinopril—systemic scleroderma	0.000245	0.0004	CcSEcCtD
Cidofovir—Headache—Captopril—systemic scleroderma	0.000244	0.000398	CcSEcCtD
Cidofovir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000397	CcSEcCtD
Cidofovir—Dyspepsia—Lisinopril—systemic scleroderma	0.000243	0.000396	CcSEcCtD
Cidofovir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000242	0.000395	CcSEcCtD
Cidofovir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000242	0.000395	CcSEcCtD
Cidofovir—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000394	CcSEcCtD
Cidofovir—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000394	CcSEcCtD
Cidofovir—Asthma—Methotrexate—systemic scleroderma	0.000241	0.000393	CcSEcCtD
Cidofovir—Infection—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000392	CcSEcCtD
Cidofovir—Decreased appetite—Lisinopril—systemic scleroderma	0.00024	0.000391	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000238	0.000388	CcSEcCtD
Cidofovir—Shock—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000388	CcSEcCtD
Cidofovir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000387	CcSEcCtD
Cidofovir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000386	CcSEcCtD
Cidofovir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000237	0.000386	CcSEcCtD
Cidofovir—Pancreatitis—Methotrexate—systemic scleroderma	0.000236	0.000385	CcSEcCtD
Cidofovir—Pain—Lisinopril—systemic scleroderma	0.000236	0.000385	CcSEcCtD
Cidofovir—Constipation—Lisinopril—systemic scleroderma	0.000236	0.000385	CcSEcCtD
Cidofovir—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000385	CcSEcCtD
Cidofovir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000383	CcSEcCtD
Cidofovir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000381	CcSEcCtD
Cidofovir—Diarrhoea—Azathioprine—systemic scleroderma	0.000233	0.000379	CcSEcCtD
Cidofovir—Nausea—Captopril—systemic scleroderma	0.000232	0.000377	CcSEcCtD
Cidofovir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000376	CcSEcCtD
Cidofovir—Asthenia—Leflunomide—systemic scleroderma	0.00023	0.000376	CcSEcCtD
Cidofovir—Hallucination—Prednisone—systemic scleroderma	0.00023	0.000374	CcSEcCtD
Cidofovir—Pancytopenia—Methotrexate—systemic scleroderma	0.000229	0.000373	CcSEcCtD
Cidofovir—Feeling abnormal—Lisinopril—systemic scleroderma	0.000227	0.000371	CcSEcCtD
Cidofovir—Pruritus—Leflunomide—systemic scleroderma	0.000227	0.00037	CcSEcCtD
Cidofovir—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000368	CcSEcCtD
Cidofovir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000226	0.000368	CcSEcCtD
Cidofovir—Neutropenia—Methotrexate—systemic scleroderma	0.000225	0.000367	CcSEcCtD
Cidofovir—Dysuria—Methotrexate—systemic scleroderma	0.000225	0.000367	CcSEcCtD
Cidofovir—Dizziness—Azathioprine—systemic scleroderma	0.000225	0.000367	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000359	CcSEcCtD
Cidofovir—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00022	0.000358	CcSEcCtD
Cidofovir—Asthenia—Mycophenolic acid—systemic scleroderma	0.00022	0.000358	CcSEcCtD
Cidofovir—Diarrhoea—Leflunomide—systemic scleroderma	0.00022	0.000358	CcSEcCtD
Cidofovir—Urticaria—Lisinopril—systemic scleroderma	0.000219	0.000357	CcSEcCtD
Cidofovir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000356	CcSEcCtD
Cidofovir—Abdominal pain—Lisinopril—systemic scleroderma	0.000218	0.000356	CcSEcCtD
Cidofovir—Body temperature increased—Lisinopril—systemic scleroderma	0.000218	0.000356	CcSEcCtD
Cidofovir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000354	CcSEcCtD
Cidofovir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000217	0.000353	CcSEcCtD
Cidofovir—Vomiting—Azathioprine—systemic scleroderma	0.000216	0.000352	CcSEcCtD
Cidofovir—Pneumonia—Methotrexate—systemic scleroderma	0.000216	0.000352	CcSEcCtD
Cidofovir—Eye disorder—Prednisone—systemic scleroderma	0.000216	0.000351	CcSEcCtD
Cidofovir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000351	CcSEcCtD
Cidofovir—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00035	CcSEcCtD
Cidofovir—Rash—Azathioprine—systemic scleroderma	0.000214	0.00035	CcSEcCtD
Cidofovir—Dermatitis—Azathioprine—systemic scleroderma	0.000214	0.000349	CcSEcCtD
Cidofovir—Flushing—Prednisone—systemic scleroderma	0.000214	0.000349	CcSEcCtD
Cidofovir—Headache—Azathioprine—systemic scleroderma	0.000213	0.000347	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000213	0.000347	CcSEcCtD
Cidofovir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000347	CcSEcCtD
Cidofovir—Dizziness—Leflunomide—systemic scleroderma	0.000212	0.000346	CcSEcCtD
Cidofovir—Renal failure—Methotrexate—systemic scleroderma	0.000211	0.000344	CcSEcCtD
Cidofovir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000343	CcSEcCtD
Cidofovir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00021	0.000342	CcSEcCtD
Cidofovir—Stomatitis—Methotrexate—systemic scleroderma	0.000209	0.000341	CcSEcCtD
Cidofovir—Angiopathy—Prednisone—systemic scleroderma	0.000209	0.000341	CcSEcCtD
Cidofovir—Conjunctivitis—Methotrexate—systemic scleroderma	0.000209	0.00034	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00034	CcSEcCtD
Cidofovir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000337	CcSEcCtD
Cidofovir—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000337	CcSEcCtD
Cidofovir—Sweating—Methotrexate—systemic scleroderma	0.000206	0.000336	CcSEcCtD
Cidofovir—Haematuria—Methotrexate—systemic scleroderma	0.000205	0.000334	CcSEcCtD
Cidofovir—Vomiting—Leflunomide—systemic scleroderma	0.000204	0.000333	CcSEcCtD
Cidofovir—Alopecia—Prednisone—systemic scleroderma	0.000204	0.000332	CcSEcCtD
Cidofovir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000203	0.000331	CcSEcCtD
Cidofovir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000203	0.00033	CcSEcCtD
Cidofovir—Epistaxis—Methotrexate—systemic scleroderma	0.000203	0.00033	CcSEcCtD
Cidofovir—Rash—Leflunomide—systemic scleroderma	0.000203	0.00033	CcSEcCtD
Cidofovir—Dermatitis—Leflunomide—systemic scleroderma	0.000202	0.00033	CcSEcCtD
Cidofovir—Nausea—Azathioprine—systemic scleroderma	0.000202	0.000329	CcSEcCtD
Cidofovir—Headache—Leflunomide—systemic scleroderma	0.000201	0.000328	CcSEcCtD
Cidofovir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000325	CcSEcCtD
Cidofovir—Asthenia—Lisinopril—systemic scleroderma	0.000198	0.000323	CcSEcCtD
Cidofovir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000322	CcSEcCtD
Cidofovir—Pruritus—Lisinopril—systemic scleroderma	0.000195	0.000318	CcSEcCtD
Cidofovir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000195	0.000318	CcSEcCtD
Cidofovir—Rash—Mycophenolic acid—systemic scleroderma	0.000193	0.000315	CcSEcCtD
Cidofovir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000193	0.000315	CcSEcCtD
Cidofovir—Hepatitis—Methotrexate—systemic scleroderma	0.000193	0.000314	CcSEcCtD
Cidofovir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000313	CcSEcCtD
Cidofovir—Headache—Mycophenolic acid—systemic scleroderma	0.000192	0.000313	CcSEcCtD
Cidofovir—Pharyngitis—Methotrexate—systemic scleroderma	0.000191	0.000312	CcSEcCtD
Cidofovir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000312	CcSEcCtD
Cidofovir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000312	CcSEcCtD
Cidofovir—Nausea—Leflunomide—systemic scleroderma	0.000191	0.000311	CcSEcCtD
Cidofovir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00019	0.00031	CcSEcCtD
Cidofovir—Urethral disorder—Methotrexate—systemic scleroderma	0.000189	0.000308	CcSEcCtD
Cidofovir—Diarrhoea—Lisinopril—systemic scleroderma	0.000189	0.000308	CcSEcCtD
Cidofovir—Ill-defined disorder—Prednisone—systemic scleroderma	0.000186	0.000304	CcSEcCtD
Cidofovir—Visual impairment—Methotrexate—systemic scleroderma	0.000186	0.000303	CcSEcCtD
Cidofovir—Anaemia—Prednisone—systemic scleroderma	0.000186	0.000303	CcSEcCtD
Cidofovir—Agitation—Prednisone—systemic scleroderma	0.000185	0.000301	CcSEcCtD
Cidofovir—Angioedema—Prednisone—systemic scleroderma	0.000184	0.000299	CcSEcCtD
Cidofovir—Dizziness—Lisinopril—systemic scleroderma	0.000183	0.000297	CcSEcCtD
Cidofovir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000182	0.000297	CcSEcCtD
Cidofovir—Nausea—Mycophenolic acid—systemic scleroderma	0.000182	0.000297	CcSEcCtD
Cidofovir—Malaise—Prednisone—systemic scleroderma	0.000181	0.000295	CcSEcCtD
Cidofovir—Vertigo—Prednisone—systemic scleroderma	0.00018	0.000294	CcSEcCtD
Cidofovir—Eye disorder—Methotrexate—systemic scleroderma	0.00018	0.000294	CcSEcCtD
Cidofovir—Syncope—Prednisone—systemic scleroderma	0.00018	0.000294	CcSEcCtD
Cidofovir—Tinnitus—Methotrexate—systemic scleroderma	0.00018	0.000293	CcSEcCtD
Cidofovir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00029	CcSEcCtD
Cidofovir—Loss of consciousness—Prednisone—systemic scleroderma	0.000177	0.000288	CcSEcCtD
Cidofovir—Vomiting—Lisinopril—systemic scleroderma	0.000176	0.000286	CcSEcCtD
Cidofovir—Angiopathy—Methotrexate—systemic scleroderma	0.000175	0.000285	CcSEcCtD
Cidofovir—Rash—Lisinopril—systemic scleroderma	0.000174	0.000284	CcSEcCtD
Cidofovir—Convulsion—Prednisone—systemic scleroderma	0.000174	0.000284	CcSEcCtD
Cidofovir—Dermatitis—Lisinopril—systemic scleroderma	0.000174	0.000283	CcSEcCtD
Cidofovir—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000174	0.000283	CcSEcCtD
Cidofovir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000283	CcSEcCtD
Cidofovir—Hypertension—Prednisone—systemic scleroderma	0.000173	0.000283	CcSEcCtD
Cidofovir—Chills—Methotrexate—systemic scleroderma	0.000173	0.000282	CcSEcCtD
Cidofovir—Headache—Lisinopril—systemic scleroderma	0.000173	0.000282	CcSEcCtD
Cidofovir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000279	CcSEcCtD
Cidofovir—Arthralgia—Prednisone—systemic scleroderma	0.000171	0.000279	CcSEcCtD
Cidofovir—Myalgia—Prednisone—systemic scleroderma	0.000171	0.000279	CcSEcCtD
Cidofovir—Anxiety—Prednisone—systemic scleroderma	0.00017	0.000278	CcSEcCtD
Cidofovir—Alopecia—Methotrexate—systemic scleroderma	0.00017	0.000278	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00017	0.000277	CcSEcCtD
Cidofovir—Discomfort—Prednisone—systemic scleroderma	0.000169	0.000275	CcSEcCtD
Cidofovir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00027	CcSEcCtD
Cidofovir—Dysgeusia—Methotrexate—systemic scleroderma	0.000164	0.000268	CcSEcCtD
Cidofovir—Nausea—Lisinopril—systemic scleroderma	0.000164	0.000267	CcSEcCtD
Cidofovir—Oedema—Prednisone—systemic scleroderma	0.000164	0.000267	CcSEcCtD
Cidofovir—Anaphylactic shock—Prednisone—systemic scleroderma	0.000164	0.000267	CcSEcCtD
Cidofovir—Infection—Prednisone—systemic scleroderma	0.000163	0.000265	CcSEcCtD
Cidofovir—Back pain—Methotrexate—systemic scleroderma	0.000162	0.000265	CcSEcCtD
Cidofovir—Shock—Prednisone—systemic scleroderma	0.000161	0.000263	CcSEcCtD
Cidofovir—Nervous system disorder—Prednisone—systemic scleroderma	0.000161	0.000262	CcSEcCtD
Cidofovir—Tachycardia—Prednisone—systemic scleroderma	0.00016	0.000261	CcSEcCtD
Cidofovir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000261	CcSEcCtD
Cidofovir—Skin disorder—Prednisone—systemic scleroderma	0.000159	0.00026	CcSEcCtD
Cidofovir—Hyperhidrosis—Prednisone—systemic scleroderma	0.000158	0.000258	CcSEcCtD
Cidofovir—Anorexia—Prednisone—systemic scleroderma	0.000156	0.000255	CcSEcCtD
Cidofovir—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000156	0.000254	CcSEcCtD
Cidofovir—Anaemia—Methotrexate—systemic scleroderma	0.000155	0.000253	CcSEcCtD
Cidofovir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000251	CcSEcCtD
Cidofovir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000249	CcSEcCtD
Cidofovir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000248	CcSEcCtD
Cidofovir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000247	CcSEcCtD
Cidofovir—Malaise—Methotrexate—systemic scleroderma	0.000151	0.000247	CcSEcCtD
Cidofovir—Vertigo—Methotrexate—systemic scleroderma	0.000151	0.000246	CcSEcCtD
Cidofovir—Leukopenia—Methotrexate—systemic scleroderma	0.00015	0.000245	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000149	0.000243	CcSEcCtD
Cidofovir—Insomnia—Prednisone—systemic scleroderma	0.000148	0.000242	CcSEcCtD
Cidofovir—Paraesthesia—Prednisone—systemic scleroderma	0.000147	0.00024	CcSEcCtD
Cidofovir—Cough—Methotrexate—systemic scleroderma	0.000147	0.000239	CcSEcCtD
Cidofovir—Convulsion—Methotrexate—systemic scleroderma	0.000145	0.000237	CcSEcCtD
Cidofovir—Dyspepsia—Prednisone—systemic scleroderma	0.000144	0.000235	CcSEcCtD
Cidofovir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000234	CcSEcCtD
Cidofovir—Myalgia—Methotrexate—systemic scleroderma	0.000143	0.000233	CcSEcCtD
Cidofovir—Chest pain—Methotrexate—systemic scleroderma	0.000143	0.000233	CcSEcCtD
Cidofovir—Arthralgia—Methotrexate—systemic scleroderma	0.000143	0.000233	CcSEcCtD
Cidofovir—Decreased appetite—Prednisone—systemic scleroderma	0.000143	0.000232	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000142	0.000231	CcSEcCtD
Cidofovir—Discomfort—Methotrexate—systemic scleroderma	0.000141	0.00023	CcSEcCtD
Cidofovir—Constipation—Prednisone—systemic scleroderma	0.00014	0.000228	CcSEcCtD
Cidofovir—Confusional state—Methotrexate—systemic scleroderma	0.000138	0.000225	CcSEcCtD
Cidofovir—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000137	0.000223	CcSEcCtD
Cidofovir—Infection—Methotrexate—systemic scleroderma	0.000136	0.000222	CcSEcCtD
Cidofovir—Feeling abnormal—Prednisone—systemic scleroderma	0.000135	0.00022	CcSEcCtD
Cidofovir—Nervous system disorder—Methotrexate—systemic scleroderma	0.000134	0.000219	CcSEcCtD
Cidofovir—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000134	0.000219	CcSEcCtD
Cidofovir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000134	0.000218	CcSEcCtD
Cidofovir—Skin disorder—Methotrexate—systemic scleroderma	0.000133	0.000217	CcSEcCtD
Cidofovir—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000132	0.000216	CcSEcCtD
Cidofovir—Anorexia—Methotrexate—systemic scleroderma	0.000131	0.000213	CcSEcCtD
Cidofovir—Urticaria—Prednisone—systemic scleroderma	0.00013	0.000212	CcSEcCtD
Cidofovir—Body temperature increased—Prednisone—systemic scleroderma	0.00013	0.000211	CcSEcCtD
Cidofovir—Abdominal pain—Prednisone—systemic scleroderma	0.00013	0.000211	CcSEcCtD
Cidofovir—Hypotension—Methotrexate—systemic scleroderma	0.000128	0.000209	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000125	0.000203	CcSEcCtD
Cidofovir—Insomnia—Methotrexate—systemic scleroderma	0.000124	0.000202	CcSEcCtD
Cidofovir—Paraesthesia—Methotrexate—systemic scleroderma	0.000123	0.0002	CcSEcCtD
Cidofovir—Dyspnoea—Methotrexate—systemic scleroderma	0.000122	0.000199	CcSEcCtD
Cidofovir—Somnolence—Methotrexate—systemic scleroderma	0.000122	0.000199	CcSEcCtD
Cidofovir—Hypersensitivity—Prednisone—systemic scleroderma	0.000121	0.000197	CcSEcCtD
Cidofovir—Dyspepsia—Methotrexate—systemic scleroderma	0.000121	0.000197	CcSEcCtD
Cidofovir—Decreased appetite—Methotrexate—systemic scleroderma	0.000119	0.000194	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000118	0.000193	CcSEcCtD
Cidofovir—Asthenia—Prednisone—systemic scleroderma	0.000118	0.000192	CcSEcCtD
Cidofovir—Pain—Methotrexate—systemic scleroderma	0.000117	0.000191	CcSEcCtD
Cidofovir—Pruritus—Prednisone—systemic scleroderma	0.000116	0.000189	CcSEcCtD
Cidofovir—Feeling abnormal—Methotrexate—systemic scleroderma	0.000113	0.000184	CcSEcCtD
Cidofovir—Diarrhoea—Prednisone—systemic scleroderma	0.000112	0.000183	CcSEcCtD
Cidofovir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000112	0.000183	CcSEcCtD
Cidofovir—Urticaria—Methotrexate—systemic scleroderma	0.000109	0.000177	CcSEcCtD
Cidofovir—Dizziness—Prednisone—systemic scleroderma	0.000108	0.000177	CcSEcCtD
Cidofovir—Abdominal pain—Methotrexate—systemic scleroderma	0.000108	0.000177	CcSEcCtD
Cidofovir—Body temperature increased—Methotrexate—systemic scleroderma	0.000108	0.000177	CcSEcCtD
Cidofovir—Vomiting—Prednisone—systemic scleroderma	0.000104	0.00017	CcSEcCtD
Cidofovir—Rash—Prednisone—systemic scleroderma	0.000103	0.000168	CcSEcCtD
Cidofovir—Dermatitis—Prednisone—systemic scleroderma	0.000103	0.000168	CcSEcCtD
Cidofovir—Headache—Prednisone—systemic scleroderma	0.000103	0.000167	CcSEcCtD
Cidofovir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000101	0.000165	CcSEcCtD
Cidofovir—Asthenia—Methotrexate—systemic scleroderma	9.83e-05	0.00016	CcSEcCtD
Cidofovir—Nausea—Prednisone—systemic scleroderma	9.74e-05	0.000159	CcSEcCtD
Cidofovir—Pruritus—Methotrexate—systemic scleroderma	9.69e-05	0.000158	CcSEcCtD
Cidofovir—Diarrhoea—Methotrexate—systemic scleroderma	9.37e-05	0.000153	CcSEcCtD
Cidofovir—Dizziness—Methotrexate—systemic scleroderma	9.06e-05	0.000148	CcSEcCtD
Cidofovir—Vomiting—Methotrexate—systemic scleroderma	8.71e-05	0.000142	CcSEcCtD
Cidofovir—Rash—Methotrexate—systemic scleroderma	8.64e-05	0.000141	CcSEcCtD
Cidofovir—Dermatitis—Methotrexate—systemic scleroderma	8.63e-05	0.000141	CcSEcCtD
Cidofovir—Headache—Methotrexate—systemic scleroderma	8.58e-05	0.00014	CcSEcCtD
Cidofovir—Nausea—Methotrexate—systemic scleroderma	8.14e-05	0.000133	CcSEcCtD
